Through our relentless dedication, we have emerged as frontrunners in the fields of oncology, hematology, transplant cases, and rare diseases. Since 2004, we have proudly partnered with over 15 international companies and extended our reach to several other Latin American nations.
Our primary focus is on developing and manufacturing high-quality pharmaceuticals, driven by an unwavering commitment to optimizing patient care. Our distinguished reputation stems from long-standing collaborations with the medical and scientific communities, where we prioritize innovation and continuous improvement in line with rigorous international quality standards.
registered
products worldwide
products in
Latin America
Varifarma Symposium: "Clinical Experience with GORAX (Relugolix 120 mg) in Advanced Prostate Cancer" at SAU Conference from April 10 to 11.
Present at the “Daily Hematology” Conference in Montevideo from March 12 to 14.
Confidence in the control of complex fungal infections.
Discover our participation in the event we joined alongside the Uruguayan Society of Medical and Pediatric Oncology.
We are expanding our portfolio with another product for breast cancer treatment.
24th Lymphoma, Leukemia, and Myeloma Congress: the ideal scenario to reaffirm our commitment.
Leading the pharmaceutical industry into the future.
We had the pleasure of attending the Hematology Update Conference on October 1st.
A record-breaking congress with the latest innovations.
A different approach to managing symptoms associated with uterine fibroids.
Connecting with the medical community at the 61st Argentine Congress of Urology, hosted by the SAU.
Setting a new standard of care in advanced prostate cancer treatment.
